DE:RGO Stock Latest News

Regeneron initiated with an Overweight at Barclays

PremiumThe Fly

3d ago

Regeneron price target raised to $765 from $745 at RBC Capital

PremiumThe Fly

7d ago

Regeneron, Sanofi announces EMA for CHMP adopted positive opinion for Dupixent

PremiumThe Fly

10d ago

Regeneron, Sanofi announce FDA approval of Dupixent for AFRS

PremiumThe Fly

13d ago

PremiumThe FlyRegeneron announces FDA accepted Priority Review for BLA for garetosmab

18d ago

Regeneron highlights expanding portfolio, pipeline at AAAI

The Fly

Regeneron highlights expanding portfolio, pipeline at AAAI

27d ago

Regeneron price target raised to $975 from $865 at Guggenheim

The Fly

Regeneron price target raised to $975 from $865 at Guggenheim

28d ago

Regeneron’s Expanding AI Use Raises Data Privacy, Regulatory and Market Risks

PremiumCompany Announcements

1M ago

Regeneron price target raised to $800 from $740 at Cantor Fitzgerald

PremiumThe Fly

1M ago

Regeneron price target raised to $742 from $630 at Baird

PremiumThe Fly

1M ago

Regeneron price target raised to $865 from $750 at Oppenheimer

PremiumThe Fly

1M ago

PremiumThe FlyRegeneron announces upcoming presentations at Angiogenesis annual meeting

1M ago

Regeneron price target raised to $950 from $850 at JPMorgan

The Fly

Regeneron price target raised to $950 from $850 at JPMorgan

1M ago

Regeneron price target raised to $800 from $745 at Wells Fargo

The Fly

Regeneron price target raised to $800 from $745 at Wells Fargo

1M ago

Regeneron price target raised to $769 from $768 at Morgan Stanley

PremiumThe Fly

1M ago

Balanced Risk/Reward Keeps Regeneron at Hold Amid Solid Fundamentals and Pipeline Uncertainty

PremiumRatings

1M ago

Regeneron’s Earnings Call: Growth Engines and Rising Costs

PremiumCompany Announcements

1M ago

Regeneron Pharmaceuticals: Robust 4Q25 Beat, Underappreciated Pipeline Upside, and 2026 Catalysts Support Buy Rating and $870 Target

PremiumRatings

1M ago

PremiumThe FlyRegeneron price target raised to $870 from $820 at Raymond James

1M ago

Regeneron reports Q4 non-GAAP EPS $11.44, consensus $10.74

The Fly

Regeneron reports Q4 non-GAAP EPS $11.44, consensus $10.74

1M ago

The Fly

Regeneron sees 2026 CapEx $1.3B

1M ago